Ilkin Hamid-Zada*, Muhammed Kose, Samer Hussein Hadi Alhaddad, Ozgur Arikan, Ozgur Kazan, Mehmet Caglar Cakici and Asif Yildirim

Department of Urology, Istanbul Medeniyet University, Istanbul, Turkey

*Corresponding Author: Ilkin Hamid-Zada, Department of Urology, Istanbul Medeniyet University, Istanbul, Turkey.

Received: May 08, 2025; Published: June 13, 2025

Abstract

Purpose: Patients with a history of urinary tract infection, antibiotic use, hospital admission, bacteriuria, diabetes mellitus, or other comorbidities may be at increased risk of infectious complications (10). Oral or intravenous antibiotics are essential before TR-PB. Cephalosporines could be a good alternative to fluoroquinolones for TR-PB prophylaxis. This study aims to show the cause of hospitalization due to febrile urinary tract infection after TR-PB.

Methods: We performed a total of 1805 prostate biopsies in the above-mentioned period. Two groups of patients were formed based on their infection status. Group 1, 1748 patients had no infectious complications after TR-PB. Group 2, 57 patients had infections related to the prostate biopsy procedure. The primary endpoint was the development of infection-related complications, including microbiologically confirmed urinary tract infection (UTI) and/or bacteremia. Secondary outcomes assessed included bacteriuria, bacteremia, hospitalizations related to infection.

Results: There were significant differences between the two arms in terms of Charlson comorbidity indexes, core number, diabetes mellitus, hypertension, IPSS, history of urinary tract infection, prior biopsy history (p < 0.05). Multivariate Cox regression analysis revealed that diabetes mellitus (HR 2.567, 95% CI 1.367-4.821, p < 0.003), hypertension (HR 3.842, 95% CI 2.176-6.782, p < 0.001), history of urinary tract infection (HR 3.526, 95% CI 1.459-8.518, p < 0.005) and core number (HR 1.278, 95% CI 1.095-1.491, p < 0.002) were independent predictors of infection after prostate biopsy.

Conclusion: Hypertension, diabetes mellitus, history of urinary tract infection and core number are independent risk factors for infection after TR-PB.

 Keywords: Prostate Biopsy; Diabetes Mellitus; Urinary Tract Infection; Cephalosporin

References

1. Pradere B., et al. “Nonantibiotic strategies for the prevention of infectious complications following prostate biopsy: a systematic review and meta-analysis”. Journal of Urology 205 (2021): 653-663.
2. Yang L., et al. “Prophylactic antibiotics in prostate biopsy: a meta-analysis based on randomized controlled trials”. Surgical Infectious 16 (2015): 733-747.
3. Borghesi M., et al. “Complications after systematic, random, and image-guided prostate biopsy”. European Urology 71 (2017): 353-365.
4. Wagenlehner FME., et al. “Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study”. European Urology 63 (2013): 521-527.
5. Lundstrom KJ., et al. “Nationwide population-based study of infections after transrectal ultrasound guided prostate biopsy”. Journal of Urology 192 (2014): 1116-1122.
6. Abughosh Z., et al. “A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy”. Journal of Urology 189 (2013): 1326-1331.
7. Derin O., et al. “Infectious complications of prostate biopsy: winning battles but not war”. World Journal of Urology 38 (2020): 2743e53.
8. Bennett HY., et al. “The global burden of major infectious complications following prostate biopsy”. Epidemiology Infectious 144 (2016): 1784e91.
9. Shigemura K and Fujisawa M. “Prevention and management of infectious complications in prostate biopsy: A review”. International Journal of Urology 28 (2021): 714-719.
10. Roberts MJ., et al. “Prostate Biopsy-related Infection: A Systematic Review of Risk Factors, Prevention Strategies, and Management Approaches”. Urology 104 (2017): 11e21.
11. Parkin CJ., et al. “Transrectal ultrasound-guided prostate needle biopsy remains a safe method in confirming a prostate cancer diagnosis: a multicentre Australian analysis of infection rates”. World Journal of Urology2 (2022): 453-458.
12. Liss MA., et al. “An update of the American Urological Association white paper on the prevention and treatment of the more common complications related to prostate biopsy”. Journal of Urology2 (2017): 329-334.
13. Naughton CK., et al. “A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection”. Journal of Urology2 (2000): 388-392.
14. Raaijmakers R., et al. “Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program”. Urology 5 (2002): 826-830.
15. Simsir A., et al. “Is it possible to predict sepsis, the most serious complication in prostate biopsy?” Urology International4 (2010): 395-399.
16. Wu YP., et al. “Risk factors for infectious complications following transrectal ultrasound-guided prostate biopsy”. Infection and Drug Resistance 11 (2018): 1491-1497.
17. Gokalp F., et al. “A novel enema method can prevent infectious complications of transrectal ultrasound-guided prostate biopsy: a single‐centre experience”. International Journal of Clinical Practice 75 (2021): e14923.
18. Utsumi T., et al. “Risk assessment of multi-factorial complications after transrectal ultrasoundguided prostate biopsy: a single institutional retrospective cohort study”. International Journal of Clinical Oncology 26 (2021): 2295-2302.
19. Choi JW., et al. “Febrile urinary tract infection after prostate biopsy and quinolone resistance”. Korean Journal of Urology10 (2014): 660-664.
20. Carignan A., et al. “Increasing risk of infectious complications after transrectal ultrasoundguided prostate biopsies: time to reassess antimicrobial prophylaxis?”. European Urology3 (2012): 453-459.
21. Steensels D., et al. “Coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy—should we reassess our practices for antibiotic prophylaxis?” Clinical Microbiology Infectious 18 (2012): 575-581.

Citation

Citation: Ilkin Hamid-Zada., et al. “Hospitalization Due to Febrile Urinary Tract Infection After Prostate Biopsy: A Comparative Analysis of 1805 Cases”.Acta Scientific Medical Sciences 9.7 (2025): 41-47.

Copyright

Copyright: © 2025 Ilkin Hamid-Zada., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.